Skip to main content

ORIGINAL RESEARCH article

Front. Psychol.
Sec. Psycho-Oncology
Volume 16 - 2025 | doi: 10.3389/fpsyg.2025.1495988

The relationship between spiritual well-being and fear of cancer progression in Iranian cancer patients

Provisionally accepted
Amir Hossein Goudarzian Amir Hossein Goudarzian 1*Pooria Sobhanian Pooria Sobhanian 2Bahar Farhadi Bahar Farhadi 3Soheyla Kalantari Soheyla Kalantari 4Mozhgan Taebi Mozhgan Taebi 5*
  • 1 Tehran University of Medical Sciences, Tehran, Iran
  • 2 Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran
  • 3 Islamic Azad University of Mashhad, Mashhad, Iran
  • 4 Golestan University of Medical Sciences, Gorgan, Golestan, Iran
  • 5 Kerman University of Medical Sciences, Kerman, Kerman, Iran

The final, formatted version of the article will be published soon.

    This study aimed to investigate the nuanced relationship between spiritual well-being and fear of cancer progression among individuals diagnosed with cancer. The study was conducted in 2023 and utilized a predictive cross-sectional survey. A total of 398 cancer patients were recruited using convenience sampling. The Spiritual Well-Being Scale (SWBS) and the Fear of Progression (FOP) scale were used for data collection. Data analysis was performed using SPSS version 26, AMOS, and JASP to assess the reliability of the constructs and the potential relationship between the two main variables. The mean age of the participants was 49.14 years (SD = 16.16, 95% CI: 47.55 50.74). All constructs demonstrated strong factorial validity and reliability. Simple linear regression analysis revealed that spiritual well-being significantly predicted fear of cancer progression (R² = 0.064, F = 27, p < 0.001). The findings indicated a significant relationship between spiritual well-being and fear of cancer progression. These results highlighted the interconnectedness of spiritual well-being and fear of cancer progression among cancer patients.

    Keywords: spiritual well-being, Fear of cancer progression, Cancer, Iran, oncology

    Received: 13 Sep 2024; Accepted: 09 Jan 2025.

    Copyright: © 2025 Goudarzian, Sobhanian, Farhadi, Kalantari and Taebi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Amir Hossein Goudarzian, Tehran University of Medical Sciences, Tehran, Iran
    Mozhgan Taebi, Kerman University of Medical Sciences, Kerman, 56131-56491, Kerman, Iran

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.